Insight Pharmaceuticals

13 articles about Insight Pharmaceuticals

• Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

  12/22/2023

  Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topical Anesthetic Spray to the consumer level.

• Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

  11/24/2023

  Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level.

• Insight Pharmaceuticals Release: MONISTAT® Announces New Suite Of Complete Care™ Products

  7/9/2014

• Insight Pharmaceuticals Reports Announces The Release Of Vaccines: The End Of Illness Report

  4/29/2014

• Medicine Distributor Prestige Brands, Inc. Scoops Up Insight Pharmaceuticals For $750 Million

  4/25/2014

• Insight Pharmaceuticals Considers "Bananacin" -- Banana-Flavored Anacin Tablets -- After World's Oldest Man Credits Combo as Secret to Long Life

  7/29/2013

• Insight Pharmaceuticals Release: MONISTAT&#0174 Announces Quest to End Unfair Stigma of Yeast Infections

  1/30/2013

• Insight Pharmaceuticals Partners with the Mommy Docs to Promote Women’s Health

  4/3/2012

• Insight Pharmaceuticals Release: e.p.t Launches Ovulation Calculator Mobile App for iPhone

  3/15/2012

• Insight Pharmaceuticals Issues a Voluntary Nationwide Recall of "Nostrilla Nasal Decongestant" Due to Bacterial Contamination

  10/20/2011

• Insight Pharmaceuticals Acquires the MONISTAT® Business in U.S. and Canada

  8/30/2011

• Insight Pharmaceuticals Acquires e.p.t®, Leading Home Pregnancy Testing Brand

  3/1/2011

• Publication in Journal of Medicinal Chemistry Highlights Molecular Insight Pharmaceuticals’ Program for Targeting Prostate Cancer

  12/30/2008